Evidence map›Paper›PMID 39601906›Full record

ArticleArchives of virology2024

Calcitriol reduces Newcastle disease virus replication by modulating galectin 3 and pro-inflammatory cytokines.

Shaurya Dumka, Chinmaya Panda, Sachin Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shaurya DumkaDepartment of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, Assam, 781039, India.
Chinmaya PandaDepartment of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, Assam, 781039, India.
Sachin KumarDepartment of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, Assam, 781039, India. sachinku@iitg.ac.in.ORCID http://orcid.org/0009-0008-1792-023X

Funding

Indian Council of Medical Research DDR/IIRP-23/2444
6 · The paper itself

Abstract

Calcitriol, or vitamin D (Vit D), is known for promoting strong bones and its ability to modulate inflammation and support the immune system. It has also been reported to be a potent antiviral agent, but the underlying mechanisms behind the mode of action are still unclear. Newcastle disease virus (NDV) belongs to the family Paramyxoviridae and causes infectious diseases in numerous avian species. In the present study, we explored the use of calcitriol as an antiviral agent against NDV infection. Post-treatment with calcitriol (the most active form of Vit D) was found to inhibit NDV replication in chicken embryo fibroblast cells (DF-1) in a time-of-addition- and concentration-dependent manner. The titer of NDV in allantoic fluid exhibited a substantial decrease after administration of cholecalciferol (the less active form of Vit D) to a 9-day-old chicken embryo. In addition, the results demonstrated a significant modulation of galectin 3 gene expression after NDV infection. Cytokine profiling of DF-1 cells treated with calcitriol and aloe-emodin, a known modulator of galectin 3, revealed significant upregulation of pro-inflammatory cytokines. The study indicates that calcitriol modulates host proteins, affecting NDV replication. These findings suggest that calcitriol or Vit D has the potential to be developed as an alternative antiviral drug against NDV, warranting further investigation.

Indexed as

Antiviral AgentsCalcitriolChickensCytokinesFibroblastsNewcastle DiseaseNewcastle disease virusVirus ReplicationAnimalsCell LineChick EmbryoGalectinsAntiviral AgentsCalcitriolCytokinesGalectins

Identifiers

PMID39601906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.